[
  {
    "ts": null,
    "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "summary": "The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.",
    "url": "https://finnhub.io/api/news?id=abccda4bdc6cd6769971fad434c2c10bdb3d21b8e80cd1c58203baf5f7e72ba8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759755604,
      "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
      "id": 136989646,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.",
      "url": "https://finnhub.io/api/news?id=abccda4bdc6cd6769971fad434c2c10bdb3d21b8e80cd1c58203baf5f7e72ba8"
    }
  },
  {
    "ts": null,
    "headline": "Moderna (MRNA): Assessing Valuation After Recent 12% Share Price Jump and Updated Financials",
    "summary": "Moderna (MRNA) has drawn attention after its stock climbed around 12% over the past week. Investors are weighing the company’s recent financial results, as annual revenue shows about 20% growth and net income margins have also improved this year. See our latest analysis for Moderna. Moderna’s recent 12% share price jump is breathing new life into a stock that’s spent much of the past year out of favor, with its latest financial results prompting renewed optimism about future growth. While the...",
    "url": "https://finnhub.io/api/news?id=d5d2aff319087fc77ee8cfbc1f28888b3764a701e306eeea9b225fdb2cb92b27",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759755492,
      "headline": "Moderna (MRNA): Assessing Valuation After Recent 12% Share Price Jump and Updated Financials",
      "id": 136990170,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) has drawn attention after its stock climbed around 12% over the past week. Investors are weighing the company’s recent financial results, as annual revenue shows about 20% growth and net income margins have also improved this year. See our latest analysis for Moderna. Moderna’s recent 12% share price jump is breathing new life into a stock that’s spent much of the past year out of favor, with its latest financial results prompting renewed optimism about future growth. While the...",
      "url": "https://finnhub.io/api/news?id=d5d2aff319087fc77ee8cfbc1f28888b3764a701e306eeea9b225fdb2cb92b27"
    }
  }
]